Pharma & Healthcare
Global Porcine Vaccines Market Research Report 2025
- Sep 09, 25
- ID: 497225
- Pages: 102
- Figures: 99
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Porcine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Vaccines.
The Porcine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Porcine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Porcine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Vaccines.
The Porcine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Porcine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Porcine Vaccines Market Overview
1.1 Product Definition
1.2 Porcine Vaccines by Type
1.2.1 Global Porcine Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Porcine Vaccines by Application
1.3.1 Global Porcine Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Vaccines Revenue 2020-2031
1.4.2 Global Porcine Vaccines Sales 2020-2031
1.4.3 Global Porcine Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Porcine Vaccines Market Competition by Manufacturers
2.1 Global Porcine Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Porcine Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Porcine Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
2.8 Global Porcine Vaccines Market Competitive Situation and Trends
2.8.1 Global Porcine Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Porcine Vaccines Players Market Share by Revenue
2.8.3 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Porcine Vaccines Market Scenario by Region
3.1 Global Porcine Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Porcine Vaccines Sales by Region: 2020-2031
3.2.1 Global Porcine Vaccines Sales by Region: 2020-2025
3.2.2 Global Porcine Vaccines Sales by Region: 2026-2031
3.3 Global Porcine Vaccines Revenue by Region: 2020-2031
3.3.1 Global Porcine Vaccines Revenue by Region: 2020-2025
3.3.2 Global Porcine Vaccines Revenue by Region: 2026-2031
3.4 North America Porcine Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Porcine Vaccines Sales by Country (2020-2031)
3.4.3 North America Porcine Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Porcine Vaccines Sales by Country (2020-2031)
3.5.3 Europe Porcine Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Porcine Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Porcine Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Porcine Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Porcine Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Porcine Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Porcine Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Porcine Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Vaccines Sales by Type (2020-2031)
4.1.1 Global Porcine Vaccines Sales by Type (2020-2025)
4.1.2 Global Porcine Vaccines Sales by Type (2026-2031)
4.1.3 Global Porcine Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Porcine Vaccines Revenue by Type (2020-2031)
4.2.1 Global Porcine Vaccines Revenue by Type (2020-2025)
4.2.2 Global Porcine Vaccines Revenue by Type (2026-2031)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Porcine Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Porcine Vaccines Sales by Application (2020-2031)
5.1.1 Global Porcine Vaccines Sales by Application (2020-2025)
5.1.2 Global Porcine Vaccines Sales by Application (2026-2031)
5.1.3 Global Porcine Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Porcine Vaccines Revenue by Application (2020-2031)
5.2.1 Global Porcine Vaccines Revenue by Application (2020-2025)
5.2.2 Global Porcine Vaccines Revenue by Application (2026-2031)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Porcine Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Porcine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Porcine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Company Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jinyu Bio-Technology Porcine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Company Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CAHIC Porcine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Company Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tecon Porcine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zoetis Porcine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Porcine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Company Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hile Bio Porcine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Company Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chopper Biology Porcine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WINSUN Porcine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Company Information
6.11.2 Hipra Description and Business Overview
6.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hipra Porcine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ringpu Biology Porcine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 DHN
6.13.1 DHN Company Information
6.13.2 DHN Description and Business Overview
6.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 DHN Porcine Vaccines Product Portfolio
6.13.5 DHN Recent Developments/Updates
6.14 CAVAC
6.14.1 CAVAC Company Information
6.14.2 CAVAC Description and Business Overview
6.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CAVAC Porcine Vaccines Product Portfolio
6.14.5 CAVAC Recent Developments/Updates
6.15 Virbac
6.15.1 Virbac Company Information
6.15.2 Virbac Description and Business Overview
6.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Virbac Porcine Vaccines Product Portfolio
6.15.5 Virbac Recent Developments/Updates
6.16 HVRI
6.16.1 HVRI Company Information
6.16.2 HVRI Description and Business Overview
6.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 HVRI Porcine Vaccines Product Portfolio
6.16.5 HVRI Recent Developments/Updates
6.17 Bioveta
6.17.1 Bioveta Company Information
6.17.2 Bioveta Description and Business Overview
6.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bioveta Porcine Vaccines Product Portfolio
6.17.5 Bioveta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Vaccines Industry Chain Analysis
7.2 Porcine Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Vaccines Production Mode & Process Analysis
7.4 Porcine Vaccines Sales and Marketing
7.4.1 Porcine Vaccines Sales Channels
7.4.2 Porcine Vaccines Distributors
7.5 Porcine Vaccines Customer Analysis
8 Porcine Vaccines Market Dynamics
8.1 Porcine Vaccines Industry Trends
8.2 Porcine Vaccines Market Drivers
8.3 Porcine Vaccines Market Challenges
8.4 Porcine Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Porcine Vaccines by Type
1.2.1 Global Porcine Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Porcine Vaccines by Application
1.3.1 Global Porcine Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Vaccines Revenue 2020-2031
1.4.2 Global Porcine Vaccines Sales 2020-2031
1.4.3 Global Porcine Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Porcine Vaccines Market Competition by Manufacturers
2.1 Global Porcine Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Porcine Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Porcine Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
2.8 Global Porcine Vaccines Market Competitive Situation and Trends
2.8.1 Global Porcine Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Porcine Vaccines Players Market Share by Revenue
2.8.3 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Porcine Vaccines Market Scenario by Region
3.1 Global Porcine Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Porcine Vaccines Sales by Region: 2020-2031
3.2.1 Global Porcine Vaccines Sales by Region: 2020-2025
3.2.2 Global Porcine Vaccines Sales by Region: 2026-2031
3.3 Global Porcine Vaccines Revenue by Region: 2020-2031
3.3.1 Global Porcine Vaccines Revenue by Region: 2020-2025
3.3.2 Global Porcine Vaccines Revenue by Region: 2026-2031
3.4 North America Porcine Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Porcine Vaccines Sales by Country (2020-2031)
3.4.3 North America Porcine Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Porcine Vaccines Sales by Country (2020-2031)
3.5.3 Europe Porcine Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Porcine Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Porcine Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Porcine Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Porcine Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Porcine Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Porcine Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Porcine Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Vaccines Sales by Type (2020-2031)
4.1.1 Global Porcine Vaccines Sales by Type (2020-2025)
4.1.2 Global Porcine Vaccines Sales by Type (2026-2031)
4.1.3 Global Porcine Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Porcine Vaccines Revenue by Type (2020-2031)
4.2.1 Global Porcine Vaccines Revenue by Type (2020-2025)
4.2.2 Global Porcine Vaccines Revenue by Type (2026-2031)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Porcine Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Porcine Vaccines Sales by Application (2020-2031)
5.1.1 Global Porcine Vaccines Sales by Application (2020-2025)
5.1.2 Global Porcine Vaccines Sales by Application (2026-2031)
5.1.3 Global Porcine Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Porcine Vaccines Revenue by Application (2020-2031)
5.2.1 Global Porcine Vaccines Revenue by Application (2020-2025)
5.2.2 Global Porcine Vaccines Revenue by Application (2026-2031)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Porcine Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Porcine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Porcine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Company Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jinyu Bio-Technology Porcine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Company Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CAHIC Porcine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Company Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tecon Porcine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zoetis Porcine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Porcine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Company Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hile Bio Porcine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Company Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chopper Biology Porcine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WINSUN Porcine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Company Information
6.11.2 Hipra Description and Business Overview
6.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hipra Porcine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ringpu Biology Porcine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 DHN
6.13.1 DHN Company Information
6.13.2 DHN Description and Business Overview
6.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 DHN Porcine Vaccines Product Portfolio
6.13.5 DHN Recent Developments/Updates
6.14 CAVAC
6.14.1 CAVAC Company Information
6.14.2 CAVAC Description and Business Overview
6.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CAVAC Porcine Vaccines Product Portfolio
6.14.5 CAVAC Recent Developments/Updates
6.15 Virbac
6.15.1 Virbac Company Information
6.15.2 Virbac Description and Business Overview
6.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Virbac Porcine Vaccines Product Portfolio
6.15.5 Virbac Recent Developments/Updates
6.16 HVRI
6.16.1 HVRI Company Information
6.16.2 HVRI Description and Business Overview
6.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 HVRI Porcine Vaccines Product Portfolio
6.16.5 HVRI Recent Developments/Updates
6.17 Bioveta
6.17.1 Bioveta Company Information
6.17.2 Bioveta Description and Business Overview
6.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bioveta Porcine Vaccines Product Portfolio
6.17.5 Bioveta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Vaccines Industry Chain Analysis
7.2 Porcine Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Vaccines Production Mode & Process Analysis
7.4 Porcine Vaccines Sales and Marketing
7.4.1 Porcine Vaccines Sales Channels
7.4.2 Porcine Vaccines Distributors
7.5 Porcine Vaccines Customer Analysis
8 Porcine Vaccines Market Dynamics
8.1 Porcine Vaccines Industry Trends
8.2 Porcine Vaccines Market Drivers
8.3 Porcine Vaccines Market Challenges
8.4 Porcine Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Porcine Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Porcine Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Porcine Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Porcine Vaccines Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Porcine Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Porcine Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Porcine Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Porcine Vaccines Average Price (USD/K Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Porcine Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Porcine Vaccines Sales by Region (2020-2025) & (M Units)
Table 18. Global Porcine Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Porcine Vaccines Sales by Region (2026-2031) & (M Units)
Table 20. Global Porcine Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Porcine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Porcine Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Porcine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Porcine Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 27. North America Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 28. North America Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 32. Europe Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 33. Europe Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Porcine Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Porcine Vaccines Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Porcine Vaccines Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Porcine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Porcine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Porcine Vaccines Sales (M Units) by Type (2020-2025)
Table 51. Global Porcine Vaccines Sales (M Units) by Type (2026-2031)
Table 52. Global Porcine Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Porcine Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Porcine Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Porcine Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Porcine Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Porcine Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Porcine Vaccines Price (USD/K Unit) by Type (2020-2025)
Table 59. Global Porcine Vaccines Price (USD/K Unit) by Type (2026-2031)
Table 60. Global Porcine Vaccines Sales (M Units) by Application (2020-2025)
Table 61. Global Porcine Vaccines Sales (M Units) by Application (2026-2031)
Table 62. Global Porcine Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Porcine Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Porcine Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Porcine Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Porcine Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Porcine Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Porcine Vaccines Price (USD/K Unit) by Application (2020-2025)
Table 69. Global Porcine Vaccines Price (USD/K Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 73. Merck Porcine Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Porcine Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Jinyu Bio-Technology Company Information
Table 81. Jinyu Bio-Technology Description and Business Overview
Table 82. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 83. Jinyu Bio-Technology Porcine Vaccines Product
Table 84. Jinyu Bio-Technology Recent Developments/Updates
Table 85. CAHIC Company Information
Table 86. CAHIC Description and Business Overview
Table 87. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 88. CAHIC Porcine Vaccines Product
Table 89. CAHIC Recent Developments/Updates
Table 90. Tecon Company Information
Table 91. Tecon Description and Business Overview
Table 92. Tecon Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 93. Tecon Porcine Vaccines Product
Table 94. Tecon Recent Developments/Updates
Table 95. Zoetis Company Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 98. Zoetis Porcine Vaccines Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 103. Ceva Porcine Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Hile Bio Company Information
Table 106. Hile Bio Description and Business Overview
Table 107. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 108. Hile Bio Porcine Vaccines Product
Table 109. Hile Bio Recent Developments/Updates
Table 110. Chopper Biology Company Information
Table 111. Chopper Biology Description and Business Overview
Table 112. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 113. Chopper Biology Porcine Vaccines Product
Table 114. Chopper Biology Recent Developments/Updates
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 118. WINSUN Porcine Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Hipra Company Information
Table 121. Hipra Description and Business Overview
Table 122. Hipra Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 123. Hipra Porcine Vaccines Product
Table 124. Hipra Recent Developments/Updates
Table 125. Ringpu Biology Company Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 128. Ringpu Biology Porcine Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. DHN Company Information
Table 131. DHN Description and Business Overview
Table 132. DHN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 133. DHN Porcine Vaccines Product
Table 134. DHN Recent Developments/Updates
Table 135. CAVAC Company Information
Table 136. CAVAC Description and Business Overview
Table 137. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 138. CAVAC Porcine Vaccines Product
Table 139. CAVAC Recent Developments/Updates
Table 140. Virbac Company Information
Table 141. Virbac Description and Business Overview
Table 142. Virbac Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 143. Virbac Porcine Vaccines Product
Table 144. Virbac Recent Developments/Updates
Table 145. HVRI Company Information
Table 146. HVRI Description and Business Overview
Table 147. HVRI Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 148. HVRI Porcine Vaccines Product
Table 149. HVRI Recent Developments/Updates
Table 150. Bioveta Company Information
Table 151. Bioveta Description and Business Overview
Table 152. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 153. Bioveta Porcine Vaccines Product
Table 154. Bioveta Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Porcine Vaccines Distributors List
Table 158. Porcine Vaccines Customers List
Table 159. Porcine Vaccines Market Trends
Table 160. Porcine Vaccines Market Drivers
Table 161. Porcine Vaccines Market Challenges
Table 162. Porcine Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Porcine Vaccines
Figure 2. Global Porcine Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Porcine Vaccines Market Share by Type: 2024 & 2031
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Porcine Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Porcine Vaccines Market Share by Application: 2024 & 2031
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Global Porcine Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Porcine Vaccines Market Size (2020-2031) & (US$ Million)
Figure 15. Global Porcine Vaccines Sales (2020-2031) & (M Units)
Figure 16. Global Porcine Vaccines Average Price (USD/K Unit) & (2020-2031)
Figure 17. Porcine Vaccines Report Years Considered
Figure 18. Porcine Vaccines Sales Share by Manufacturers in 2024
Figure 19. Global Porcine Vaccines Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Porcine Vaccines Players: Market Share by Revenue in Porcine Vaccines in 2024
Figure 21. Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Porcine Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 24. North America Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 25. the United States Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 28. Europe Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 29. Germany Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. UK Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Porcine Vaccines Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Porcine Vaccines Revenue Market Share by Region (2020-2031)
Figure 36. China Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 46. Latin America Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Porcine Vaccines by Type (2020-2031)
Figure 56. Global Revenue Market Share of Porcine Vaccines by Type (2020-2031)
Figure 57. Global Porcine Vaccines Price (USD/K Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Porcine Vaccines by Application (2020-2031)
Figure 59. Global Revenue Market Share of Porcine Vaccines by Application (2020-2031)
Figure 60. Global Porcine Vaccines Price (USD/K Unit) by Application (2020-2031)
Figure 61. Porcine Vaccines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Porcine Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Porcine Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Porcine Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Porcine Vaccines Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Porcine Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Porcine Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Porcine Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Porcine Vaccines Average Price (USD/K Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Porcine Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Porcine Vaccines Sales by Region (2020-2025) & (M Units)
Table 18. Global Porcine Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Porcine Vaccines Sales by Region (2026-2031) & (M Units)
Table 20. Global Porcine Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Porcine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Porcine Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Porcine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Porcine Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 27. North America Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 28. North America Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 32. Europe Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 33. Europe Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Porcine Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Porcine Vaccines Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Porcine Vaccines Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Porcine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Porcine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Porcine Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Porcine Vaccines Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Porcine Vaccines Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Porcine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Porcine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Porcine Vaccines Sales (M Units) by Type (2020-2025)
Table 51. Global Porcine Vaccines Sales (M Units) by Type (2026-2031)
Table 52. Global Porcine Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Porcine Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Porcine Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Porcine Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Porcine Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Porcine Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Porcine Vaccines Price (USD/K Unit) by Type (2020-2025)
Table 59. Global Porcine Vaccines Price (USD/K Unit) by Type (2026-2031)
Table 60. Global Porcine Vaccines Sales (M Units) by Application (2020-2025)
Table 61. Global Porcine Vaccines Sales (M Units) by Application (2026-2031)
Table 62. Global Porcine Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Porcine Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Porcine Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Porcine Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Porcine Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Porcine Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Porcine Vaccines Price (USD/K Unit) by Application (2020-2025)
Table 69. Global Porcine Vaccines Price (USD/K Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 73. Merck Porcine Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Porcine Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Jinyu Bio-Technology Company Information
Table 81. Jinyu Bio-Technology Description and Business Overview
Table 82. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 83. Jinyu Bio-Technology Porcine Vaccines Product
Table 84. Jinyu Bio-Technology Recent Developments/Updates
Table 85. CAHIC Company Information
Table 86. CAHIC Description and Business Overview
Table 87. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 88. CAHIC Porcine Vaccines Product
Table 89. CAHIC Recent Developments/Updates
Table 90. Tecon Company Information
Table 91. Tecon Description and Business Overview
Table 92. Tecon Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 93. Tecon Porcine Vaccines Product
Table 94. Tecon Recent Developments/Updates
Table 95. Zoetis Company Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 98. Zoetis Porcine Vaccines Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 103. Ceva Porcine Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Hile Bio Company Information
Table 106. Hile Bio Description and Business Overview
Table 107. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 108. Hile Bio Porcine Vaccines Product
Table 109. Hile Bio Recent Developments/Updates
Table 110. Chopper Biology Company Information
Table 111. Chopper Biology Description and Business Overview
Table 112. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 113. Chopper Biology Porcine Vaccines Product
Table 114. Chopper Biology Recent Developments/Updates
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 118. WINSUN Porcine Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Hipra Company Information
Table 121. Hipra Description and Business Overview
Table 122. Hipra Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 123. Hipra Porcine Vaccines Product
Table 124. Hipra Recent Developments/Updates
Table 125. Ringpu Biology Company Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 128. Ringpu Biology Porcine Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. DHN Company Information
Table 131. DHN Description and Business Overview
Table 132. DHN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 133. DHN Porcine Vaccines Product
Table 134. DHN Recent Developments/Updates
Table 135. CAVAC Company Information
Table 136. CAVAC Description and Business Overview
Table 137. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 138. CAVAC Porcine Vaccines Product
Table 139. CAVAC Recent Developments/Updates
Table 140. Virbac Company Information
Table 141. Virbac Description and Business Overview
Table 142. Virbac Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 143. Virbac Porcine Vaccines Product
Table 144. Virbac Recent Developments/Updates
Table 145. HVRI Company Information
Table 146. HVRI Description and Business Overview
Table 147. HVRI Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 148. HVRI Porcine Vaccines Product
Table 149. HVRI Recent Developments/Updates
Table 150. Bioveta Company Information
Table 151. Bioveta Description and Business Overview
Table 152. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
Table 153. Bioveta Porcine Vaccines Product
Table 154. Bioveta Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Porcine Vaccines Distributors List
Table 158. Porcine Vaccines Customers List
Table 159. Porcine Vaccines Market Trends
Table 160. Porcine Vaccines Market Drivers
Table 161. Porcine Vaccines Market Challenges
Table 162. Porcine Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Porcine Vaccines
Figure 2. Global Porcine Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Porcine Vaccines Market Share by Type: 2024 & 2031
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Porcine Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Porcine Vaccines Market Share by Application: 2024 & 2031
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Global Porcine Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Porcine Vaccines Market Size (2020-2031) & (US$ Million)
Figure 15. Global Porcine Vaccines Sales (2020-2031) & (M Units)
Figure 16. Global Porcine Vaccines Average Price (USD/K Unit) & (2020-2031)
Figure 17. Porcine Vaccines Report Years Considered
Figure 18. Porcine Vaccines Sales Share by Manufacturers in 2024
Figure 19. Global Porcine Vaccines Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Porcine Vaccines Players: Market Share by Revenue in Porcine Vaccines in 2024
Figure 21. Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Porcine Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 24. North America Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 25. the United States Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 28. Europe Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 29. Germany Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. UK Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Porcine Vaccines Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Porcine Vaccines Revenue Market Share by Region (2020-2031)
Figure 36. China Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 46. Latin America Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Porcine Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Porcine Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Porcine Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Porcine Vaccines by Type (2020-2031)
Figure 56. Global Revenue Market Share of Porcine Vaccines by Type (2020-2031)
Figure 57. Global Porcine Vaccines Price (USD/K Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Porcine Vaccines by Application (2020-2031)
Figure 59. Global Revenue Market Share of Porcine Vaccines by Application (2020-2031)
Figure 60. Global Porcine Vaccines Price (USD/K Unit) by Application (2020-2031)
Figure 61. Porcine Vaccines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232